First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer (FOIB)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Gruppo Oncologico del Nord-Ovest

ClinicalTrials.gov Identifier:

NCT01163396

First received: July 9, 2010

Last updated: March 10, 2015

Last verified: March 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2010
Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):